Orion Biotechnology Canada announced it is receiving advisory services and conditional funding from the National Research Council Industrial Research Assistance Program (NRC IRAP), to support the development of Orion’s lead compound, OB-002 ...
Orion Biotechnology Canada Ltd., a clinical stage pharmaceutical company, is receiving advisory services and conditional funding from the National Research Council Industrial Research Assistance Program (NRC IRAP) to support the development of Orion’s ...